IRADIMED CORPORATION has grown revenue 13% a year over three years and 20% a year over five, with earnings per share compounding at 15%. Revenue growth, 3-year annual rate: +13% (Medical Devices median +12%). Revenue growth, 5-year rate: +20%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +15%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 13, FY2013 to FY2025, as filed.

IRMDIRADIMED CORPORATION

Healthcare

$87.53+26% 1Y

$87.53

$67.7752 weeks$104.87

Is it growing?

Excellent

Growing: revenue growing +11% year on year, earnings up +10% year on year, and operating margin widening (+1.3 points).

3 good

Revenue trend+11% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +20% a year.

Earnings trend+10% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+1.3 points operating

Trailing-twelve-month operating margin, 31.9% now against 30.7% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 76% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IRMD growing?

IRADIMED CORPORATION has grown revenue 13% a year over three years and 20% a year over five, with earnings per share compounding at 15%.

+13%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +20%
Revenue growth, 5-year rate · +13% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +15%
Earnings per share, 3-year rate · revenue +13% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed